Abstract
Background: Methotrexate (MTX) is an antineoplastic drug that is widely used in the treatment of neoplasms. Patients undergoing MTX therapy have a variety of side effects affecting many important organs. Aim of the work: The aim of the present study was to detect the histological and the immunohistochemical adverse alterations that might occur in the jejunum of the adult albino rats following methotrexate therapy and to determine the possible protective role of vitamin A. Material and Methods: Seventy two adult male albino rats were divided into six equal groups. In all groups the animals were sacrificed 24 hours after the last injection. The jejunal specimens were examined using H& E and Masson’s trichrome stains and immunohistochemical examination to study the alkaline phosphatase activity using light microscopy. Morphometric study measuring villous height, crypt depth, number of goblet cells, percentage area of fibrosis and the optical density of alkaline phosphatase activity was done in all groups. Results: The methotrexate treated groups’ revealed different changes in the jejunum of rats. Distortion and cystic dilatation of the crypts, cellular shedding and dilated blood vessels were found. Morphometric study showed decreased villus height and goblet cells, increased the crypts depth. Immunohistochemical examination of the jejunal sections of the methotrexate treated groups showed weak reaction of alkaline phosphatase enzyme when compared with that of the control group. Conclusion: It can be concluded that the toxic effect of methotrexate on the jejunum of rats can be partially improved with the concomitant use of vitamin A.
Highlights
Methotrexate (MTX) is used for the therapy of a wide range of neoplastic disorders including acute lymphoblastic leukemia, nonHodgkin’s lymphoma, breast cancer and testicular tumors [1]
It can be concluded that the toxic effect of methotrexate on the jejunum of rats can be partially improved with the concomitant use of vitamin A
As methotrexate (MTX) is an anti-metabolite drug, it is widely used in the treatment of many diseases such as rheumatoid arthritis and psoriasis [4]
Summary
Methotrexate (MTX) is used for the therapy of a wide range of neoplastic disorders including acute lymphoblastic leukemia, nonHodgkin’s lymphoma, breast cancer and testicular tumors [1]. Concerning the effect of MTX on the small intestine, Miyazono et al [5] mentioned that the oxidative stress plays an important role in the MTX-induced small intestinal damage. Ciralik et al [6] mentioned that methotrexate caused damage to the mucosa of small intestine leading to nausea, vomiting, diarrhea, stomatitis, decreased absorption and gastrointestinal (GI) ulceration. The latter authors reported that biopsies of the small intestinal epithelium of patients treated with MTX exhibited an increase in the oxidative stress and a decrease in antioxidant defenses. Patients undergoing MTX therapy have a variety of side effects affecting many important organs
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
